Dr Parag Gajendragadkar was appointed as a Consultant Electrophysiologist at Royal Papworth Hospital which he combines alongside a research appointment at the University of Oxford in the Department of Population Health.
He studied medicine at the University of Cambridge (Downing College) with a number of prizes and distinctions across both undergraduate and clinical medical studies. He was a Wellcome Trust funded academic clinical fellow and completed an MPhil in translational medicine and therapeutics, focussing on translating promising drug compounds into early human studies.
He started cardiology specialist training within the East of England in 2012. As a British Heart Foundation-funded clinical research fellow he completed a DPhil (PhD) from the University of Oxford which encompassed both basic science and animal work as well as genetic epidemiology, for which he was awarded the European Society of Cardiology Young Investigator Award for Population Sciences in 2019.
After completing specialist cardiology training in Royal Papworth, he then spent a further two years as a post-CCT senior clinical electrophysiology fellow back in Oxford at the John Radcliffe Hospital, performing a high volume and variety of procedures.
Subsequently, he was appointed to a Consultant post combining clinical work here at Royal Papworth with ongoing research broadly within the field of arrhythmias in the Oxford Department of Population Health.
Cardiology, Electrophysiology and Devices (Pacemakers and ICDs)
- Arrhythmias
- Atrial fibrillation and stroke
- Catheter ablation of arrhythmias
- Device therapy and extraction
- MA Medical Sciences, Downing College, University of Cambridge, 2005
- MB BChir (with Distinction), University of Cambridge, 2008
- MPhil (with Distinction), Translational Medicine and Therapeutics, University of Cambridge, 2012
- DPhil in Medical Sciences, University of Oxford, 2020
- Member of the General Medical Council (registration number: 7016846)
- Member of the Royal College of Physicians, London
- Member of the British Cardiac Society
- Member of the British Heart Rhythm Society
- Certified Cardiac Device Specialist, International Board of Heart Rhythm Examiners, 2018
- Senior Clinical Research Fellow, Oxford Department of Population Health, University of Oxford
- Visiting Research Fellow, University of Cambridge
Selected publications listed below with a comprehensive list available on Google Scholar or ORCID.
Gajendragadkar PR, Von Ende A, Murgia F, Offer A, Camm CF, Wijesurendra RS, Casadei B, Hopewell JC. Discrete mechanistic pathways underlying genetic predisposition to atrial fibrillation are associated with different intermediate cardiac phenotypes and risk of cardioembolic stroke medRxiv – 2024
Camm CF, Lacey B, Massa MS, Von Ende A, Gajendragadkar P, Stiby A, Valdes-Marquez E, Lewington S, Wijesurendra R, Parish S, Casadei B, Hopewell JC. Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5 million individuals. Int J Epidemiol – 2022
Gajendragadkar PR, Von Ende A, Ibrahim M, Valdes-Marquez E, Camm CF, Murgia F, Stiby A, Casadei B, Hopewell JC. Assessment of the causal relevance of ECG parameters for risk of atrial fibrillation: A Mendelian randomisation study. PLoS Med – 2021
Simon JN, Vrellaku B, Monterisi S, Chu SM, Rawlings N, Lomas O, Marchal GA, Waithe D, Syeda F, Gajendragadkar PR, Jayaram R, Sayeed R, Channon KM, Fabritz L, Swietach P, Zaccolo M, Eaton P, Casadei B. Oxidation of Protein Kinase A Regulatory Subunit PKARIα Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release. Circulation – 2021
Gajendragadkar PR, Hubsch A, Mäki-Petäjä KM, Serg M, Wilkinson IB, Cheriyan J. Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial. PLoS One – 2014
